{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T03:30:15Z","timestamp":1785382215141,"version":"3.55.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T00:00:00Z","timestamp":1682380800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T00:00:00Z","timestamp":1682380800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Despite lack of survival benefit, demand for contralateral prophylactic mastectomy (CPM) to treat unilateral breast cancer remains high. High uptake of CPM has been demonstrated in Midwestern rural women. Greater travel distance for surgical treatment is associated with CPM. Our objective was to examine the relationship between rurality and travel distance to surgery with CPM.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Women diagnosed with stages I\u2013III unilateral breast cancer between 2007 and 2017 were identified using the National Cancer Database. Logistic regression was used to model likelihood of CPM based on rurality, proximity to metropolitan centers, and travel distance. A multinomial logistic regression model compared factors associated with CPM with reconstruction versus other surgical options.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Both rurality (OR 1.10, 95% CI 1.06\u20131.15 for non-metro\/rural vs. metro) and travel distance (OR 1.37, 95% CI 1.33\u20131.41 for those who traveled 50\u2009+\u2009miles vs.\u2009&lt;\u200930 miles) were independently associated with CPM. For women who traveled 30\u2009+\u2009miles, odds of receiving CPM were highest for non-metro\/rural women (OR 1.33 for 30\u201349 miles, OR 1.57 for 50\u2009+\u2009miles; reference: metro women traveling\u2009&lt;\u200930 miles). Non-metro\/rural women who received reconstruction were more likely to undergo CPM regardless of travel distance (ORs 1.11\u20131.21). Both metro and metro-adjacent women who received reconstruction were more likely to undergo CPM only if they traveled 30\u2009+\u2009miles (ORs 1.24\u20131.30).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The impact of travel distance on likelihood of CPM varies by patient rurality and receipt of reconstruction. Further research is needed to understand how patient residence, travel burden, and geographic access to comprehensive cancer care services, including reconstruction, influence patient decisions regarding surgery.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s10552-023-01689-9","type":"journal-article","created":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T03:36:27Z","timestamp":1682393787000},"page":"171-186","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Effect of rurality and travel distance on contralateral prophylactic mastectomy for unilateral breast cancer"],"prefix":"10.1007","volume":"34","author":[{"given":"Madison M.","family":"Wahlen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid M.","family":"Lizarraga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda R.","family":"Kahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Whitney E.","family":"Zahnd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan M.","family":"Eberth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Overholser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natoshia","family":"Askelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Hirschey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Yeager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Nash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacklyn M.","family":"Engelbart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary E.","family":"Charlton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,25]]},"reference":[{"key":"1689_CR1","unstructured":"SEER Cancer Stat Facts: Female Breast Cancer. National Cancer Institute. Bethesda, MD.\u202fhttps:\/\/seer.cancer.gov\/statfacts\/html\/breast.html"},{"key":"1689_CR2","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.amsu.2020.06.016","volume":"56","author":"M Riis","year":"2020","unstructured":"Riis M (2020) Modern surgical treatment of breast cancer. Ann Med Surg (Lond) 56:95\u2013107. https:\/\/doi.org\/10.1016\/j.amsu.2020.06.016","journal-title":"Ann Med Surg (Lond)"},{"issue":"3","key":"1689_CR3","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1097\/sla.0000000000001698","volume":"265","author":"SM Wong","year":"2017","unstructured":"Wong SM, Freedman RA, Sagara Y, Aydogan F, Barry WT, Golshan M (2017) Growing use of contralateral prophylactic mastectomy despite no improvement in long-term survival for invasive breast cancer. Ann Surg 265(3):581\u2013589. https:\/\/doi.org\/10.1097\/sla.0000000000001698","journal-title":"Ann Surg"},{"issue":"10","key":"1689_CR4","doi-asserted-by":"publisher","first-page":"3231","DOI":"10.1245\/s10434-014-3956-3","volume":"21","author":"C Pesce","year":"2014","unstructured":"Pesce C, Liederbach E, Wang C, Lapin B, Winchester DJ, Yao K (2014) Contralateral prophylactic mastectomy provides no survival benefit in young women with estrogen receptor-negative breast cancer. Ann Surg Oncol 21(10):3231\u20133239. https:\/\/doi.org\/10.1245\/s10434-014-3956-3","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"1689_CR5","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1245\/s10434-017-5983-3","volume":"24","author":"JC Boughey","year":"2017","unstructured":"Boughey JC, Schilz SR, Van Houten HK, Zhu L, Habermann EB, Lemaine V (2017) Contralateral prophylactic mastectomy with immediate breast reconstruction increases healthcare utilization and cost. Ann Surg Oncol 24(10):2957\u20132964. https:\/\/doi.org\/10.1245\/s10434-017-5983-3","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"1689_CR6","doi-asserted-by":"publisher","first-page":"3100","DOI":"10.1245\/s10434-016-5443-5","volume":"23","author":"JC Boughey","year":"2016","unstructured":"Boughey JC, Attai DJ, Chen SL, Cody HS, Dietz JR, Feldman SM, Greenberg CC, Kass RB, Landercasper J, Lemaine V, MacNeill F, Song DH, Staley AC, Wilke LG, Willey SC, Yao KA, Margenthaler JA (2016) Contralateral Prophylactic Mastectomy\u00a0(CPM) consensus statement from the American Society of Breast Surgeons: Data on CPM Outcomes and Risks. Ann Surg Oncol 23(10):3100\u20133105. https:\/\/doi.org\/10.1245\/s10434-016-5443-5","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"1689_CR7","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1245\/s10434-016-5688-z","volume":"24","author":"KK Hunt","year":"2017","unstructured":"Hunt KK, Euhus DM, Boughey JC, Chagpar AB, Feldman SM, Hansen NM, Kulkarni SA, McCready DR, Mamounas EP, Wilke LG, Van Zee KJ, Morrow M (2017) Society of Surgical Oncology Breast Disease Working Group Statement on prophylactic (risk-reducing) mastectomy. Ann Surg Oncol 24(2):375\u2013397. https:\/\/doi.org\/10.1245\/s10434-016-5688-z","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"1689_CR8","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1097\/sla.0000000000002309","volume":"267","author":"FC Wright","year":"2018","unstructured":"Wright FC, Look Hong NJ, Quan ML, Beyfuss K, Temple S, Covelli A, Baxter N, Gagliardi AR (2018) Indications for contralateral prophylactic mastectomy: a consensus statement using modified Delphi methodology. Ann Surg 267(2):271\u2013279. https:\/\/doi.org\/10.1097\/sla.0000000000002309","journal-title":"Ann Surg"},{"issue":"6","key":"1689_CR9","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1001\/jamasurg.2013.5689","volume":"149","author":"ST Hawley","year":"2014","unstructured":"Hawley ST, Jagsi R, Morrow M, Janz NK, Hamilton A, Graff JJ, Katz SJ (2014) Social and clinical determinants of contralateral prophylactic mastectomy. JAMA Surg 149(6):582\u2013589. https:\/\/doi.org\/10.1001\/jamasurg.2013.5689","journal-title":"JAMA Surg"},{"issue":"25","key":"1689_CR10","doi-asserted-by":"publisher","first-page":"2630","DOI":"10.1200\/jco.2018.78.6442","volume":"36","author":"PA Parker","year":"2018","unstructured":"Parker PA, Peterson SK, Shen Y, Bedrosian I, Black DM, Thompson AM, Nelson JC, DeSnyder SM, Cook RL, Hunt KK, Volk RJ, Cantor SB, Dong W, Brewster AM (2018) Prospective study of psychosocial outcomes of having contralateral prophylactic mastectomy among women with nonhereditary breast cancer. J Clin Oncol 36(25):2630\u20132638. https:\/\/doi.org\/10.1200\/jco.2018.78.6442","journal-title":"J Clin Oncol"},{"issue":"6","key":"1689_CR11","doi-asserted-by":"publisher","first-page":"373","DOI":"10.7326\/0003-4819-159-6-201309170-00003","volume":"159","author":"SM Rosenberg","year":"2013","unstructured":"Rosenberg SM, Tracy MS, Meyer ME, Sepucha K, Gelber S, Hirshfield-Bartek J, Troyan S, Morrow M, Schapira L, Come SE, Winer EP, Partridge AH (2013) Perceptions, knowledge, and satisfaction with contralateral prophylactic mastectomy among young women with breast cancer: a cross-sectional survey. Ann Intern Med 159(6):373\u2013381. https:\/\/doi.org\/10.7326\/0003-4819-159-6-201309170-00003","journal-title":"Ann Intern Med"},{"issue":"6","key":"1689_CR12","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1002\/pon.4683","volume":"27","author":"SM Rosenberg","year":"2018","unstructured":"Rosenberg SM, Greaney ML, Patenaude AF, Sepucha KR, Meyer ME, Partridge AH (2018) \u201cI don\u2019t want to take chances\u201d: a qualitative exploration of surgical decision making in young breast cancer survivors. Psychooncology 27(6):1524\u20131529. https:\/\/doi.org\/10.1002\/pon.4683","journal-title":"Psychooncology"},{"issue":"1","key":"1689_CR13","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/prs.0000000000002263","volume":"138","author":"PJ Buchanan","year":"2016","unstructured":"Buchanan PJ, Abdulghani M, Waljee JF, Kozlow JH, Sabel MS, Newman LA, Chung KC, Momoh AO (2016) An analysis of the decisions made for contralateral prophylactic mastectomy and breast reconstruction. Plast Reconstr Surg 138(1):29\u201340. https:\/\/doi.org\/10.1097\/prs.0000000000002263","journal-title":"Plast Reconstr Surg"},{"issue":"23","key":"1689_CR14","doi-asserted-by":"publisher","first-page":"4547","DOI":"10.1002\/cncr.30924","volume":"123","author":"ST Hawley","year":"2017","unstructured":"Hawley ST, Griffith KA, Hamilton AS, Ward KC, Morrow M, Janz NK, Katz SJ, Jagsi R (2017) The association between patient attitudes and values and the strength of consideration for contralateral prophylactic mastectomy in a population-based sample of breast cancer patients. Cancer 123(23):4547\u20134555. https:\/\/doi.org\/10.1002\/cncr.30924","journal-title":"Cancer"},{"issue":"1","key":"1689_CR15","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.amjsurg.2018.11.040","volume":"218","author":"J Huang","year":"2019","unstructured":"Huang J, Chagpar A (2019) Factors associated with decision to undergo contralateral prophylactic mastectomy versus unilateral mastectomy. Am J Surg 218(1):170\u2013174. https:\/\/doi.org\/10.1016\/j.amjsurg.2018.11.040","journal-title":"Am J Surg"},{"issue":"1","key":"1689_CR16","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.jamcollsurg.2015.03.033","volume":"221","author":"L Grimmer","year":"2015","unstructured":"Grimmer L, Liederbach E, Velasco J, Pesce C, Wang CH, Yao K (2015) Variation in contralateral prophylactic mastectomy rates according to racial groups in young women with breast cancer, 1998 to 2011: a report from the National Cancer Data Base. J Am Coll Surg 221(1):187\u2013196. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2015.03.033","journal-title":"J Am Coll Surg"},{"issue":"2","key":"1689_CR17","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1089\/jwh.2018.7350","volume":"29","author":"B Jerome-D'Emilia","year":"2020","unstructured":"Jerome-D\u2019Emilia B, Trinh H (2020) Socioeconomic factors associated with the receipt of contralateral prophylactic mastectomy in women with breast cancer. J Womens Health (Larchmt) 29(2):220\u2013229. https:\/\/doi.org\/10.1089\/jwh.2018.7350","journal-title":"J Womens Health (Larchmt)"},{"issue":"3","key":"1689_CR18","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1001\/jamasurg.2016.4749","volume":"152","author":"R Jagsi","year":"2017","unstructured":"Jagsi R, Hawley ST, Griffith KA, Janz NK, Kurian AW, Ward KC, Hamilton AS, Morrow M, Katz SJ (2017) Contralateral prophylactic mastectomy decisions in a population-based sample of patients with early-stage breast cancer. JAMA Surg 152(3):274\u2013282. https:\/\/doi.org\/10.1001\/jamasurg.2016.4749","journal-title":"JAMA Surg"},{"issue":"10","key":"1689_CR19","doi-asserted-by":"publisher","first-page":"3038","DOI":"10.1245\/s10434-017-5985-1","volume":"24","author":"EP Ward","year":"2017","unstructured":"Ward EP, Unkart JT, Bryant A, Murphy J, Blair SL (2017) Influence of distance to hospital and insurance status on the rates of contralateral prophylactic mastectomy, a National Cancer Data Base study. Ann Surg Oncol 24(10):3038\u20133047. https:\/\/doi.org\/10.1245\/s10434-017-5985-1","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"1689_CR20","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1245\/s10434-020-08376-y","volume":"27","author":"S Obeng-Gyasi","year":"2020","unstructured":"Obeng-Gyasi S, Timsina L, Bhattacharyya O, Fisher CS, Haggstrom DA (2020) Breast cancer presentation, surgical management and mortality across the rural-urban continuum in the national cancer database. Ann Surg Oncol 27(6):1805\u20131815. https:\/\/doi.org\/10.1245\/s10434-020-08376-y","journal-title":"Ann Surg Oncol"},{"key":"1689_CR21","doi-asserted-by":"publisher","first-page":"107497","DOI":"10.1155\/2011\/107497","volume":"2011","author":"GK Singh","year":"2011","unstructured":"Singh GK, Williams SD, Siahpush M, Mulhollen A (2011) Socioeconomic, rural-urban, and racial inequalities in US Cancer Mortality: Part I-All Cancers and Lung Cancer and Part II-Colorectal, Prostate, Breast, and Cervical Cancers. J Cancer Epidemiol 2011:107497. https:\/\/doi.org\/10.1155\/2011\/107497","journal-title":"J Cancer Epidemiol"},{"issue":"7","key":"1689_CR22","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1001\/jamasurg.2017.0115","volume":"152","author":"R Nash","year":"2017","unstructured":"Nash R, Goodman M, Lin CC, Freedman RA, Dominici LS, Ward K, Jemal A (2017) State variation in the receipt of a contralateral prophylactic mastectomy among women who received a diagnosis of invasive unilateral early-stage breast cancer in the United States, 2004\u20132012. JAMA Surg 152(7):648\u2013657. https:\/\/doi.org\/10.1001\/jamasurg.2017.0115","journal-title":"JAMA Surg"},{"issue":"1","key":"1689_CR23","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s10549-021-06105-x","volume":"188","author":"IM Lizarraga","year":"2021","unstructured":"Lizarraga IM, Kahl AR, Jacoby E, Charlton ME, Lynch CF, Sugg SL (2021) Impact of age, rurality and distance in predicting contralateral prophylactic mastectomy for breast cancer in a Midwestern state: a population-based study. Breast Cancer Res Treat 188(1):191\u2013202. https:\/\/doi.org\/10.1007\/s10549-021-06105-x","journal-title":"Breast Cancer Res Treat"},{"issue":"8","key":"1689_CR24","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1007\/s10552-013-0225-x","volume":"24","author":"KE Weaver","year":"2013","unstructured":"Weaver KE, Palmer N, Lu L, Case LD, Geiger AM (2013) Rural-urban differences in health behaviors and implications for health status among US cancer survivors. Cancer Causes Control 24(8):1481\u20131490. https:\/\/doi.org\/10.1007\/s10552-013-0225-x","journal-title":"Cancer Causes Control"},{"issue":"5","key":"1689_CR25","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1056\/NEJMhpr1707176","volume":"378","author":"JK Iglehart","year":"2018","unstructured":"Iglehart JK (2018) The challenging quest to improve rural health care. N Engl J Med 378(5):473\u2013479. https:\/\/doi.org\/10.1056\/NEJMhpr1707176","journal-title":"N Engl J Med"},{"issue":"14","key":"1689_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.ss6614a1","volume":"66","author":"SJ Henley","year":"2017","unstructured":"Henley SJ, Anderson RN, Thomas CC, Massetti GM, Peaker B, Richardson LC (2017) Invasive cancer incidence, 2004\u20132013, and deaths, 2006\u20132015, in nonmetropolitan and metropolitan counties - United States. MMWR Surveill Summ 66(14):1\u201313. https:\/\/doi.org\/10.15585\/mmwr.ss6614a1","journal-title":"MMWR Surveill Summ"},{"issue":"28","key":"1689_CR27","doi-asserted-by":"publisher","first-page":"3177","DOI":"10.1200\/jco.2015.61.1558","volume":"33","author":"CC Lin","year":"2015","unstructured":"Lin CC, Bruinooge SS, Kirkwood MK, Olsen C, Jemal A, Bajorin D, Giordano SH, Goldstein M, Guadagnolo BA, Kosty M, Hopkins S, Yu JB, Arnone A, Hanley A, Stevens S, Hershman DL (2015) Association between geographic access to cancer care, insurance, and receipt of chemotherapy: geographic distribution of oncologists and travel distance. J Clin Oncol 33(28):3177\u20133185. https:\/\/doi.org\/10.1200\/jco.2015.61.1558","journal-title":"J Clin Oncol"},{"issue":"1","key":"1689_CR28","doi-asserted-by":"publisher","first-page":"622","DOI":"10.4081\/gh.2018.622","volume":"13","author":"Y Lin","year":"2018","unstructured":"Lin Y, Wimberly MC, Da Rosa P, Hoover J, Athas WF (2018) Geographic access to radiation therapy facilities and disparities of early-stage breast cancer treatment. Geospat Health 13(1):622. https:\/\/doi.org\/10.4081\/gh.2018.622","journal-title":"Geospat Health"},{"issue":"2","key":"1689_CR29","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.pec.2006.06.003","volume":"65","author":"GN Polacek","year":"2007","unstructured":"Polacek GN, Ramos MC, Ferrer RL (2007) Breast cancer disparities and decision-making among U.S. women. Patient Educ Couns 65(2):158\u2013165. https:\/\/doi.org\/10.1016\/j.pec.2006.06.003","journal-title":"Patient Educ Couns"},{"key":"1689_CR30","unstructured":"American College of Surgeons. National Cancer Database. www.facs.org\/quality-programs\/cancer\/ncdb"},{"key":"1689_CR31","unstructured":"National Cancer Database Participant User File 2019 Data Dictionary. https:\/\/www.facs.org\/media\/440j2ray\/puf_data_dictionary_2019.pdf"},{"issue":"3","key":"1689_CR32","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1111\/1475-6773.13951","volume":"57","author":"WE Zahnd","year":"2022","unstructured":"Zahnd WE, Del Vecchio N, Askelson N, Eberth JM, Vanderpool RC, Overholser L, Madhivanan P, Hirschey R, Edward J (2022) Definition and categorization of rural and assessment of realized access to care. Health Serv Res 57(3):693\u2013702. https:\/\/doi.org\/10.1111\/1475-6773.13951","journal-title":"Health Serv Res"},{"issue":"2","key":"1689_CR33","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1093\/tbm\/iby133","volume":"10","author":"SL Manne","year":"2020","unstructured":"Manne SL, Smith BL, Frederick S, Mitarotondo A, Kashy DA, Kirstein LJ (2020) B-Sure: a randomized pilot trial of an interactive web-based decision support aid versus usual care in average-risk breast cancer patients considering contralateral prophylactic mastectomy. Transl Behav Med 10(2):355\u2013363. https:\/\/doi.org\/10.1093\/tbm\/iby133","journal-title":"Transl Behav Med"},{"issue":"1","key":"1689_CR34","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1245\/s10434-016-5556-x","volume":"24","author":"K Yao","year":"2017","unstructured":"Yao K, Belkora J, Bedrosian I, Rosenberg S, Sisco M, Barrera E, Kyrillios A, Tilburt J, Wang C, Rabbitt S, Pesce C, Simovic S, Winchester DJ, Sepucha K (2017) Impact of an in-visit decision aid on patient knowledge about contralateral prophylactic mastectomy: a pilot study. Ann Surg Oncol 24(1):91\u201399. https:\/\/doi.org\/10.1245\/s10434-016-5556-x","journal-title":"Ann Surg Oncol"},{"key":"1689_CR35","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.breast.2018.05.009","volume":"40","author":"B Ager","year":"2018","unstructured":"Ager B, Jansen J, Porter D, Phillips KA, Glassey R, Butow P (2018) Development and pilot testing of a Decision Aid (DA) for women with early-stage breast cancer considering contralateral prophylactic mastectomy. Breast 40:156\u2013164. https:\/\/doi.org\/10.1016\/j.breast.2018.05.009","journal-title":"Breast"},{"issue":"1","key":"1689_CR36","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1097\/prs.0000000000001847","volume":"137","author":"CR Albornoz","year":"2016","unstructured":"Albornoz CR, Cohen WA, Razdan SN, Mehrara BJ, McCarthy CM, Disa JJ, Dayan JH, Pusic AL, Cordeiro PG, Matros E (2016) The impact of travel distance on breast reconstruction in the United States. Plast Reconstr Surg 137(1):12\u201318. https:\/\/doi.org\/10.1097\/prs.0000000000001847","journal-title":"Plast Reconstr Surg"},{"key":"1689_CR37","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jss.2020.12.057","volume":"262","author":"AS Baskin","year":"2021","unstructured":"Baskin AS, Wang T, Bredbeck BC, Sinco BR, Berlin NL, Dossett LA (2021) Trends in contralateral prophylactic mastectomy utilization for small unilateral breast cancer. J Surg Res 262:71\u201384. https:\/\/doi.org\/10.1016\/j.jss.2020.12.057","journal-title":"J Surg Res"},{"issue":"7","key":"1689_CR38","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1001\/jamasurg.2017.0458","volume":"152","author":"SJ Katz","year":"2017","unstructured":"Katz SJ, Janz NK, Abrahamse P, Wallner LP, Hawley ST, An LC, Ward KC, Hamilton AS, Morrow M, Jagsi R (2017) Patient reactions to surgeon recommendations about contralateral prophylactic mastectomy for treatment of breast cancer. JAMA Surg 152(7):658\u2013664. https:\/\/doi.org\/10.1001\/jamasurg.2017.0458","journal-title":"JAMA Surg"},{"key":"1689_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.gore.2021.100868","volume":"38","author":"V Mujumdar","year":"2021","unstructured":"Mujumdar V, Butler TR, Shalowitz DI (2021) A qualitative study on the impact of long-distance travel for gynecologic cancer care. Gynecol Oncol Rep 38:100868","journal-title":"Gynecol Oncol Rep"},{"issue":"25","key":"1689_CR40","doi-asserted-by":"publisher","first-page":"4177","DOI":"10.1200\/jco.2008.21.7018","volume":"27","author":"KY Bilimoria","year":"2009","unstructured":"Bilimoria KY, Bentrem DJ, Stewart AK, Winchester DP, Ko CY (2009) Comparison of commission on cancer-approved and -nonapproved hospitals in the United States: implications for studies that use the National Cancer Data Base. J Clin Oncol 27(25):4177\u20134181. https:\/\/doi.org\/10.1200\/jco.2008.21.7018","journal-title":"J Clin Oncol"},{"issue":"12","key":"1689_CR41","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1001\/jamaoncol.2016.6905","volume":"3","author":"DJ Boffa","year":"2017","unstructured":"Boffa DJ, Rosen JE, Mallin K, Loomis A, Gay G, Palis B, Thoburn K, Gress D, McKellar DP, Shulman LN, Facktor MA, Winchester DP (2017) Using the National Cancer Database for Outcomes Research: a review. JAMA Oncol 3(12):1722\u20131728. https:\/\/doi.org\/10.1001\/jamaoncol.2016.6905","journal-title":"JAMA Oncol"},{"issue":"13","key":"1689_CR42","doi-asserted-by":"publisher","first-page":"8752","DOI":"10.1245\/s10434-021-10426-y","volume":"28","author":"IM Lizarraga","year":"2021","unstructured":"Lizarraga IM, Schroeder MC, Jatoi I, Sugg SL, Trentham-Dietz A, Hoeth L, Chrischilles EA (2021) Surgical decision-making surrounding contralateral prophylactic mastectomy: comparison of treatment goals, preferences, and psychosocial outcomes from a multicenter survey of breast cancer patients. Ann Surg Oncol 28(13):8752\u20138765. https:\/\/doi.org\/10.1245\/s10434-021-10426-y","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"1689_CR43","doi-asserted-by":"publisher","first-page":"3088","DOI":"10.1002\/cam4.2914","volume":"9","author":"K Yao","year":"2020","unstructured":"Yao K, Bleicher R, Moran M, Chang C, Dietz J, Stearns V, Connolly J, Sarantou T, Kurtzman S (2020) Differences in physician opinions about controversial issues surrounding contralateral prophylactic mastectomy (CPM): a survey of physicians from accredited breast centers in the United States. Cancer Med 9(9):3088\u20133096. https:\/\/doi.org\/10.1002\/cam4.2914","journal-title":"Cancer Med"},{"key":"1689_CR44","unstructured":"Nelson HD, Fu R, Goddard K, et al (2013) U.S. Preventive Services Task Force Evidence Syntheses, formerly Systematic Evidence Reviews. In: Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: Systematic Review to Update the U.S. Preventive Services Task Force Recommendation. Rockville (MD): Agency for Healthcare Research and Quality (US)"}],"container-title":["Cancer Causes &amp; Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-023-01689-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10552-023-01689-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-023-01689-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T16:04:36Z","timestamp":1701360276000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10552-023-01689-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,25]]},"references-count":44,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["1689"],"URL":"https:\/\/doi.org\/10.1007\/s10552-023-01689-9","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"value":"0957-5243","type":"print"},{"value":"1573-7225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,25]]},"assertion":[{"value":"4 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"As the dataset is publicly available and de-identified, no institutional review board approval was required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}